[
    [
        {
            "time": "2023-10-10",
            "orginal_text": "舍得酒业高管变动：财务负责人辞职，新聘任4名副总裁一半来自复星系 董监高成员变化",
            "features": {
                "keywords": [
                    "舍得酒业",
                    "高管变动",
                    "财务负责人辞职",
                    "复星系"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "舍得酒业高管变动：财务负责人辞职，新聘任4名副总裁一半来自复星系 董监高成员变化",
            "scores": {
                "News_content": "舍得酒业高管变动：财务负责人辞职，新聘任4名副总裁一半来自复星系 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "舍得酒业任命4名副总裁，复星系邹庆利接任首席财务官",
            "features": {
                "keywords": [
                    "舍得酒业",
                    "副总裁",
                    "复星系",
                    "首席财务官"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "舍得酒业任命4名副总裁，复星系邹庆利接任首席财务官",
            "scores": {
                "News_content": "舍得酒业任命4名副总裁，复星系邹庆利接任首席财务官",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药(02196)附属公司复锐医疗科技(01696)建议采纳受限制股份单位计划",
            "features": {
                "keywords": [
                    "复星医药",
                    "复锐医疗科技",
                    "受限制股份单位计划"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药(02196)附属公司复锐医疗科技(01696)建议采纳受限制股份单位计划",
            "scores": {
                "News_content": "复星医药(02196)附属公司复锐医疗科技(01696)建议采纳受限制股份单位计划",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "青岛啤酒：股东复星集团累积减持H股超5%至6822.23万股 减持股份",
            "features": {
                "keywords": [
                    "青岛啤酒",
                    "复星集团",
                    "减持H股"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "啤酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "青岛啤酒：股东复星集团累积减持H股超5%至6822.23万股 减持股份",
            "scores": {
                "News_content": "青岛啤酒：股东复星集团累积减持H股超5%至6822.23万股 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药(02196.HK)：Sisram批准建议采纳受限制股份单位计划",
            "features": {
                "keywords": [
                    "复星医药",
                    "Sisram",
                    "受限制股份单位计划"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药(02196.HK)：Sisram批准建议采纳受限制股份单位计划",
            "scores": {
                "News_content": "复星医药(02196.HK)：Sisram批准建议采纳受限制股份单位计划",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药(600196.SH)控股子公司复锐医疗科技拟推受限制股份单位计划",
            "features": {
                "keywords": [
                    "复星医药",
                    "复锐医疗科技",
                    "受限制股份单位计划"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药(600196.SH)控股子公司复锐医疗科技拟推受限制股份单位计划",
            "scores": {
                "News_content": "复星医药(600196.SH)控股子公司复锐医疗科技拟推受限制股份单位计划",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药：拟向副总裁刘毅授出22万份Sisram受限制股份单位",
            "features": {
                "keywords": [
                    "复星医药",
                    "副总裁",
                    "Sisram",
                    "受限制股份单位"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药：拟向副总裁刘毅授出22万份Sisram受限制股份单位",
            "scores": {
                "News_content": "复星医药：拟向副总裁刘毅授出22万份Sisram受限制股份单位",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药：董事会审议通过关于参与对复星凯特生物科技有限公司增资的议案",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星凯特",
                    "增资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药：董事会审议通过关于参与对复星凯特生物科技有限公司增资的议案",
            "scores": {
                "News_content": "复星医药：董事会审议通过关于参与对复星凯特生物科技有限公司增资的议案",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "青岛啤酒(600600.SH)股东复星集团累积减持H股6822.23万股 减持股份",
            "features": {
                "keywords": [
                    "青岛啤酒",
                    "复星集团",
                    "减持H股"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "啤酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "青岛啤酒(600600.SH)股东复星集团累积减持H股6822.23万股 减持股份",
            "scores": {
                "News_content": "青岛啤酒(600600.SH)股东复星集团累积减持H股6822.23万股 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "医药业周报：从“PB-ROE” 医药投资“性价比”已现",
            "features": {
                "keywords": [
                    "医药业",
                    "PB-ROE",
                    "投资性价比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药业周报：从“PB-ROE” 医药投资“性价比”已现",
            "scores": {
                "News_content": "医药业周报：从“PB-ROE” 医药投资“性价比”已现",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "orginal_text": "复星医药：目前已完成国内多家顶级医院端治疗中心的认证",
            "features": {
                "keywords": [
                    "复星医药",
                    "顶级医院",
                    "治疗中心认证"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药：目前已完成国内多家顶级医院端治疗中心的认证",
            "scores": {
                "News_content": "复星医药：目前已完成国内多家顶级医院端治疗中心的认证",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]